^ abNestler JE, Jakubowicz DJ, Reamer P, Gunn RD, Allan G (1999). “Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome”. N. Engl. J. Med.340 (17): 1314–20. doi:10.1056/NEJM199904293401703. PMID10219066.
^ abIuorno MJ, Jakubowicz DJ, Baillargeon JP; et al. (2002年). "Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome". Endocrine practice. 8 (6): 417–23. PMID15251831。
^Nestler JE, Jakubowicz DJ, Iuorno MJ (2000). “Role of inositolphosphoglycan mediators of insulin action in the polycystic ovary syndrome”. J. Pediatr. Endocrinol. Metab.. 13 Suppl 5: 1295–8. PMID11117673.